Back to map
Miroculus

Miroculus

San Francisco, United States · from Greece
Acquired
SaaS

The main product is a microfluidics platform designed for fully automated sample preparation in next generation sequencing (NGS), utilizing digital microfluidics technology to enable unattended processing and reduce reagent consumption. It employs MIRO cartridges and microfluidic channels to streamline workflows for applications such as long-read sequencing and target enrichment.

Founded

2012

Employees

3

Total Raised

$48M

Valuation

$111M

CEE Connection

CEE-Origin Founder

Open Positions (0)

No open positions at the moment